NCT03891212

Brief Summary

Enrollment criteria and clinical data collection: follow the principles of medical ethics, the development of inclusion and exclusion criteria, Select all eligible patients with severe pneumonia(SP) who were admitted to the hospital during the study date.The diagnostic criteria we will use for SP are based on the Infectious Diseases Society of America/American Thoracic Society guidelines.Primary outcome measures:a.CURB-65 Score for Pneumonia Severity;b.The changes in inflammation and coagulation indicators: C-reactive protein, procalcitonin, and d-dimer;c.Chest x-ray changes;d.Mortality rate after 28 days;e.The time of mechanical ventilation, total duration of ICU stay, hospitalization, and antibiotic use;f.The time of bacterial cultures becoming negative;g.Daily sputum drainage.The aim of this study is to evaluate the anti-infective effectiveness and safety of prone position drainage compared with supine position on SP treatment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 18, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 26, 2019

Completed
6 days until next milestone

Study Start

First participant enrolled

April 1, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2022

Completed
Last Updated

March 26, 2019

Status Verified

March 1, 2019

Enrollment Period

2 years

First QC Date

March 18, 2019

Last Update Submit

March 25, 2019

Conditions

Keywords

Prone PositionTreatment OutcomeRespiration, Artificial

Outcome Measures

Primary Outcomes (11)

  • The changes in C-reactive protein

    Use C-reactive protein to assess the patient's lung infection status

    On the tenth day after hospitalization

  • The changes in procalcitonin

    Use procalcitonin to assess the patient's lung infection status

    On the tenth day after hospitalization

  • The changes in d-dimer

    Use d-dimer to assess the patient's lung infection status

    On the tenth day after hospitalization

  • Chest x-ray changes

    Use Chest x-ray to assess the patient's lung infection status

    On the tenth day after hospitalization

  • Mortality rate after 28 days

    Calculate patient 28-day mortality

    28 days after admission

  • The time of total duration of ICU stay

    Calculate The time of total duration of ICU stay

    28 day

  • The time of mechanical ventilation

    Calculate The time of mechanical ventilation

    28 day

  • mortality

    Using the Kaplan-Meier method to analyze the differences in mortality between the two groups within 28 days

    28 day

  • The time of antibiotic use

    Calculate the time of antibiotic use

    28 day

  • The time of bacterial cultures becoming negative

    Calculate the time of bacterial cultures becoming negative

    28 day

  • Daily sputum drainage

    Calculate daily sputum drainage

    On the tenth day after hospitalization

Study Arms (2)

The prone group

EXPERIMENTAL

Patients assigned to the prone group had to be turned within the first hour following randomization. They were placed in prone position for at least 16 consecutive hours.

Behavioral: Placed in prone position for at least 16 consecutive hours a day.

The supine group

NO INTERVENTION

Patients assigned to the supine group had to be turned within the first hour following randomization. They were placed in supine position for at least 16 consecutive hours.

Interventions

Patients assigned to the prone group had to be turned within the first hour following randomization. They were placed in prone position for at least 16 consecutive hours. Patients assigned to the control group had to be turned within the first hour following randomization. They were placed in supine position for at least 16 consecutive hours.

The prone group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years and ≤75 years, male or female
  • Weight ≥40 kg and ≤100 kg
  • Meet the diagnostic criteria for SP
  • Need invasive mechanical ventilation
  • Provide signed informed consent

You may not qualify if:

  • Contraindication for prone positioning:a. Intracranial pressure \>30 mm Hg or cerebral perfusion pressure \<60 mmHg;b. Massive hemoptysis requiring an immediate surgical or interventional radiology procedure; c. Tracheal surgery or sternotomy during the previous 15 days;d. Serious facial trauma or facial surgery during the previous 15 days;e. Deep venous thrombosis treated for less than 2 days; f. Cardiac pacemaker inserted in the last 2 days;g. Unstable spine, femur, or pelvic fractures;h. Mean arterial pressure lower than 65 mm Hg;i. Pregnant women; j. Single anterior chest tube with air leaks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Xiangya Hospital

Changsha, Hunan, 410008, China

Location

MeSH Terms

Conditions

PneumoniaRespiratory Aspiration

Interventions

Prone Position

Condition Hierarchy (Ancestors)

Respiratory Tract InfectionsInfectionsLung DiseasesRespiratory Tract DiseasesRespiration DisordersPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

PostureMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Pinhua Pan, Doctor

    Xiangya Hospital of Central South University

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Using a central randomization system, participants will be randomized (1:1) into groups receiving either placed in prone position or in supine position (within 24 h of diagnosis of SP) for 5-7 days with a 28-day follow-up. Patients assigned to the prone group had to be turned within the first hour following randomization. They were placed in prone position for at least 16 consecutive hours.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 18, 2019

First Posted

March 26, 2019

Study Start

April 1, 2019

Primary Completion

April 1, 2021

Study Completion

April 1, 2022

Last Updated

March 26, 2019

Record last verified: 2019-03

Locations